Category

AAPM News

Home / AAPM News

Optimizing Telehealth Pain Care After COVID-19

The COVID-19 pandemic has presented major challenges to pain care, as pain clinicians face severe restrictions in their ability to provide usual in-person assessments and treatments. COVID-19 has also exposed prepandemic problems in providing comprehensive pain care. Yet, despite this crisis, there have been encouraging developments for long-term delivery of pain services, most notably the explosive growth in the adoption of telehealth technology and clinical resourcefulness in its applications. Read more.

CALL FOR APPLICATIONS: EDITOR-IN-CHIEF, Pain Medicine

The American Academy of Pain Medicine (AAPM) announces the search for Editor-in-Chief (EIC) of its journal, Pain Medicine, published by Oxford University Press.

Scope

Pain Medicine is unique amongst dedicated pain journals because it has always emphasized the need to represent the breadth of scholarship in clinical and translational pain research.It has always published what is relevant to the field, and, as a result, it is the only pain journal with dedicated sections for each of the major areas in our field. Pain Medicine is a forum for empirical findings, systematic reviews, and conceptual papers. The EIC is expected to be a recognized national or international leader in our specialty, with a scholarly track record and a record of high-level performance in previous journal activities either within or outside the specialty of pain medicine. The EIC position is estimated to require 20 hours per week, or approximately 40% professional effort, with anticipated effort being distributed 5 days a week.Duties will include managing the virtual editorial office, senior associate editors, section editors, and the relationship with our publisher, Oxford University Press. The Editor-in-Chief will receive an annual salary + an incentive component based on journal performance. The EIC will also participate as an ex officio member of the AAPM Executive Committee.

Applications

Interested individuals should submit their CV and a brief cover letter conveying why they are interested in the position and the strengths of their skill set they would bring to the journal.

We are requesting these materials by Monday, December 7th at the latest. An AAPM task force will review all applications and discuss next steps with each candidate.

Please submit your application to Phil Saigh, AAPM Executive Director, at [email protected]

Sincerely,

Ajay D. Wasan, MD MSc

President, AAPM

What We Know So Far About How COVID Affects the Nervous System

Many of the symptoms experienced by people infected with SARS-CoV-2 involve the nervous system. Patients complain of headaches, muscle and joint pain, fatigue and “brain fog,” or loss of taste and smell — all of which can last from weeks to months after infection. In severe cases, COVID-19 can also lead to encephalitis or stroke. The virus has undeniable neurological effects. But the way it actually affects nerve cells still remains a bit of a mystery. Can immune system activation alone produce symptoms? Or does the novel coronavirus directly attack the nervous system? Read more.

American Academy of Pain Medicine Rejects “Fake News”

The American Academy of Pain Medicine stands by our colleagues in the AMA to condemn the statements by President Trump referenced in a recent New York Times article, regarding accusations of profit and self-interest in taking care of patients during the pandemic. Physicians have put themselves and their families at risk in executing their Hippocratic oath to treat patients despite the personal risks. In addition to balancing the treatment of acute and chronic pain with the need to keep our patients safe from COVID, a majority of our members are anesthesiologists, many of whom are working in hospitals to take care of the critically ill as well. At AAPM we support our members’ selfless dedication to our patients, despite the risks of personal harm.

Study Bolsters Patient-Controlled Analgesia for Cancer Pain

AAPM member Kenneth Candido, MD, comments on a study regarding patient-controlled analgesia (PCA) IV hydromorphone titration provides quicker analgesic effect, higher patient satisfaction and a similar tolerability compared with non-PCA administration in patients with severe cancer pain. The findings come from a phase 3, randomized clinical trial involving 214 patients that was presented at the American Society of Clinical Oncology. Read more.

1 2 3 12 13
Pain Medicine Journal
Access to this page is restricted to members only! Not a mamber? Join Now!

Ask Us Anything. Anytime.

📝 Fill in your details and we’ll get back to you in no time.
AAPM

American Academy of Pain Medicine